gebhart/patrepeval huggingface dataset:
Pneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2 (1991)

The immunoregulatory function of the complement system has been the focus of many investigations. In particular, fragments of complement factor C3 have been shown to play a role in B-lymphocyte activation and proliferation, lymphokine production, and the generation of in vitro antibody production. Purified pneumococcal polysaccharides (PS) can induce direct activation of C3 via the alternative pathway. Using sera of C1q-deficient patients and healthy subjects, we demonstrated that C3d, a split product of C3 that is generated after degradation of iC3b, can be bound to PS antigens. The binding of C3d to PS can occur in the absence of specific antibodies. Subsequently, we showed that PS complexed with C3d can be recognized by complement receptor type 2 that is expressed on B cells. Treatment of B cells with a monoclonal antibody recognizing the C3d-binding site of complement receptor type 2 reduces the binding of PS-C3d to the cells. In addition, we showed that PS4 complexed with C3d exerted an increased immunogenicity compared with free PS4. Our results show that the complement system plays a role in the activation of PS-specific B cells, carrying membrane receptors for C3d. Consequently, the complement system plays a regulatory role in the antibody response to T-cell-independent type 2 antigens such as PS.
Functional significance of a deep intronic mutation in the ATM gene and evidence for an alternative exon 28a (2005)

Screening for ATM mutations is usually performed using genomic DNA as a template for PCR amplification across exonic regions, with the consequence that deep intronic sequences are not analyzed. Here we report a novel pseudoexon-retaining deep intronic mutation (IVS28-159A>G; g.75117A>G based on GenBank U82828.1) in a patient with ataxia-telangiectasia (A-T), as well as the identification of a previously unrecognized alternative exon in the ATM gene (exon 28a) expressed in lymphoblastoid cell lines (LCL) derived from normal individuals. cDNA analysis using the A-T patient's LCL showed the retention of two aberrant intronic segments of 112 and 190 nt between exons 28 and 29. Minigenes were constructed to determine the functional significance of two genomic changes in the region of aberrant splicing: IVS28-193C>T (g.75083C>T) and IVS28-159A>G, revealing that: 1) the first is a polymorphism; 2) IVS28-159A>G weakens the 5' splice site of the alternative exon 28a and activates a cryptic 5' splice site (ss) 83 nt downstream; and 3) wild-type constructs also retain a 29-nt segment (exon 28a) as part of both the 112- and 190-nt segments. Maximum entropy estimates of ss strengths corroborate the cDNA and minigene findings. Such mutations may prove relevant in planning therapy that targets specific splicing aberrations.
Fatal Familial Insomnia, a Prion Disease with a Mutation at Codon 178 of the Prion Protein Gene (1992)

Fatal familial insomnia is a prion disease with a mutation in codon 178 of the PrP gene, but the disease phenotype seems to differ from that of previously described kindreds with the same point mutation.
High-resolution miniature FTIR spectrometer enabled by a large linear travel MEMS pop-up mirror (2009)

This paper reports the design, fabrication, and characterization of a millimeter diameter, surface micromachined Micro-Electro-Mechanical-Systems (MEMS) mirror, which is assembled perpendicular to the substrate and can be linearly and repeatedly traversed through 600 &mu;m. The moving mirror, when combined with a fixed mirror and beamsplitter, make up a monolithic MEMS Michelson interferometer; all are made on the same substrate and in the same surface micromachined fabrication process. The beamsplitter has been specifically designed such that the motion of the mirror enables modulation of light over the 2-14 &mu;m spectral region. The rapid scan MEMS Michelson interferometer is the engine behind a miniaturized, Fourier transform infrared (FTIR) absorption spectrometer. The FTIR measures the absorption of infrared (IR) radiation by a target material, which can be used for the detection and identification of gases, liquids, or solids. The fabrication of the mirror with the ability to displace 600 &mu;m along the optical axis enables the miniaturized system to have species identification resolution, while leveraging wafer scale batch fabrication to enable extremely low system cost. The successful fabrication of the millimeter diameter mirrors and beamsplitter with interferometric alignment over the range of travel of the moving mirror promises unprecedented sensitivity relative to the size of the FTIR spectrometer system.
A urine inhibitor of interleukin 1 activity that blocks ligand binding. (1987)

Urine from febrile patients was found to contain a novel inhibitor of interleukin 1 (IL-1) bioactivity that blocked the specific binding of radioiodinated IL-1 to its receptor in a dose-dependent fashion. Strong inhibition of IL-1 binding was still obtained when cells were preincubated with the inhibitor and washed, thus suggesting that the inhibitor binds to a surface structure (possibly the IL-1 receptor itself). The inhibitor was distinct from IL-1 as determined by both physical parameters (size and antigenicity) and receptor-binding characteristics (apparent affinity and dissociation rate). These data provide evidence for a physiologic regulator of IL-1 activity that functions in vivo via direct interference with ligand binding.
Extraordinary Cohesiveness of a Boronic Acid-Based Calix[6]arene Monolayer at the Air−Water Interface (1996)

ADVERTISEMENT RETURN TO ISSUEPREVNoteExtraordinary Cohesiveness of a Boronic Acid-Based Calix[6]arene Monolayer at the Air−Water InterfaceRobert A. Hendel, Vaclav Janout, Woongki Lee, and Steven L. RegenView Author Information Department of Chemistry and Zettlemoyer Center for Surface Studies, Lehigh University, Bethlehem, Pennsylvania 18015 Cite this: Langmuir 1996, 12, 23, 5745–5746Publication Date (Web):November 13, 1996Publication History Received10 June 1996Published online13 November 1996Published inissue 1 January 1996https://pubs.acs.org/doi/10.1021/la960567mhttps://doi.org/10.1021/la960567mbrief-reportACS PublicationsCopyright © 1996 American Chemical SocietyRequest reuse permissionsArticle Views178Altmetric-Citations7LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Interfaces,Molecules,Monolayers,Noncovalent interactions,Thin films Get e-Alerts
BCI2000: A General-Purpose Brain-Computer Interface (BCI) System (2004)

Many laboratories have begun to develop brain-computer interface (BCI) systems that provide communication and control capabilities to people with severe motor disabilities. Further progress and realization of practical applications depends on systematic evaluations and comparisons of different brain signals, recording methods, processing algorithms, output formats, and operating protocols. However, the typical BCI system is designed specifically for one particular BCI method and is, therefore, not suited to the systematic studies that are essential for continued progress. In response to this problem, we have developed a documented general-purpose BCI research and development platform called BCI2000. BCI2000 can incorporate alone or in combination any brain signals, signal processing methods, output devices, and operating protocols. This report is intended to describe to investigators, biomedical engineers, and computer scientists the concepts that the BC12000 system is based upon and gives examples of successful BCI implementations using this system. To date, we have used BCI2000 to create BCI systems for a variety of brain signals, processing methods, and applications. The data show that these systems function well in online operation and that BCI2000 satisfies the stringent real-time requirements of BCI systems. By substantially reducing labor and cost, BCI2000 facilitates the implementation of different BCI systems and other psychophysiological experiments. It is available with full documentation and free of charge for research or educational purposes and is currently being used in a variety of studies by many research groups.
Therapy of muscle wasting in cancer: what is the future? (2004)

Purpose of review The aim of the present review is to provide insights into the future therapeutic approaches to cancer-related muscle wasting that flow from the progressive knowledge of mechanisms regulating muscle mass in health and disease. Recent findings Cancer cachexia is a severely debilitating and life-threatening paraneoplastic syndrome accounting for approximately 20% of cancer deaths. The prominent clinical feature of cancer cachexia is the progressive loss of muscle mass, which is substantially not reversible with any of the currently available nutritional, metabolic or pharmacological approaches. Cancer cachexia has long been considered a late event in the natural history of cancer patients, thus condemning them to merely palliative interventions. The accumulating evidence that the metabolic and molecular derangements ultimately leading to muscle wasting are operating early after tumour onset, even when weight loss is minimal or absent, is strengthening the view that cancer cachexia should be considered an early phenomenon. Summary Currently, despite scientific and economic efforts, the therapy of cancer-related muscle wasting has a poor success rate. Present knowledge of the intracellular mechanisms involved in muscle homeoastasis is prompting continuous research aimed at developing more effective and selective therapeutic tools for the prevention and treatment of muscle loss in cancer.
The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity (2001)

The infected cell protein 0 (ICP0) of herpes simplex virus 1, a promiscuous transactivator shown to enhance the expression of genes introduced into cells by infection or transfection, interacts with numerous cellular proteins and has been linked to the disruption of ND10 and degradation of several proteins. ICP0 contains a RING finger domain characteristic of a class of E3 ubiquitin ligases. We report that: (i) in infected cells, ICP0 interacts dynamically with proteasomes and is bound to proteasomes in the presence of the proteasome inhibitor MG132. Also in infected cells, cdc34, a polyubiquitinated E2 ubiquitin-conjugating enzyme, exhibits increased ICP0-dependent dynamic interaction with proteasomes. (ii) In an in vitro substrate-independent ubiquitination system, the RING finger domain encoded by exon 2 of ICP0 binds cdc34, whereas the carboxyl-terminal domain of ICP0 functions as an E3 ligase independent of the RING finger domain. The results indicate that ICP0 can act as a unimolecular E3 ubiquitin ligase and that it promotes ubiquitin-protein ligation and binds the E2 cdc34. It differs from other unimolecular E3 ligases in that the domain containing the RING finger binds E2, whereas the ligase activity maps to a different domain of the protein. The results also suggest that ICP0 shuttles between nucleus and cytoplasm as a function of its dynamic interactions with proteasomes.
TCRs Used in Cancer Gene Therapy Cross-React with MART-1/Melan-A Tumor Antigens via Distinct Mechanisms (2011)

T cells engineered to express TCRs specific for tumor Ags can drive cancer regression. The first TCRs used in cancer gene therapy, DMF4 and DMF5, recognize two structurally distinct peptide epitopes of the melanoma-associated MART-1/Melan-A protein, both presented by the class I MHC protein HLA-A*0201. To help understand the mechanisms of TCR cross-reactivity and provide a foundation for the further development of immunotherapy, we determined the crystallographic structures of DMF4 and DMF5 in complex with both of the MART-1/Melan-A epitopes. The two TCRs use different mechanisms to accommodate the two ligands. Although DMF4 binds the two with a different orientation, altering its position over the peptide/MHC, DMF5 binds them both identically. The simpler mode of cross-reactivity by DMF5 is associated with higher affinity toward both ligands, consistent with the superior functional avidity of DMF5. More generally, the observation of two diverging mechanisms of cross-reactivity with the same Ags and the finding that TCR-binding orientation can be determined by peptide alone extend our understanding of the mechanisms underlying TCR cross-reactivity.
Gaussian white-noise generation for digital signal synthesis (1986)

An algorithm for simulating a random Gaussian noise signal on a computer is proposed. The power spectrum of the generated signal is constant, and the ordinates of the phase spectrum are independent and uniformly distributed. A computer program has been developed based on this algorithm and used with a signal generator to test electronic systems.
Review of the NAEPP 2007 Expert Panel Report (EPR-3) on Asthma Diagnosis and Treatment Guidelines (2008)

The complexity of asthma and its treatment has necessitated the development of several guidelines from the NAEPP, with the most recent EPR-3 update being released in late August 2007. One expert consensus has distilled the EPR-3 document into 7 key educational messages that can assist the health care professional in improving the care of the patient with asthma.
Chiral Preparation of (R)- and (S)-3-(Benzyloxy)-4,4-dimethyl-1-pentene (1993)

Facile routes for the preparation of an optically active allylic ether bearing the tert-butyl group at an allylic chiral center, i.e. 2-(benzyloxy)-3,3-dimethyl-1-pentene, in both (R)- and (S)-enantiomeric forms, which are expected to be promising, efficient dipolarophiles in highly stereoselective asymmetric nitrone cycloaddition, have been developed, utilizing commercially available L-tert-leucine and (R)-pantolactone, respectively, as chiral precursors.
Kabat Database and its applications: future directions (2001)

The Kabat Database was initially started in 1970 to determine the combining site of antibodies based on the available amino acid sequences. The precise delineation of complementarity determining regions (CDR) of both light and heavy chains provides the first example of how properly aligned sequences can be used to derive structural and functional information of biological macromolecules. This knowledge has subsequently been applied to the construction of artificial antibodies with prescribed specificities, and to many other studies. The Kabat database now includes nucleotide sequences, sequences of T cell receptors for antigens (TCR), major histocompatibility complex (MHC) class I and II molecules, and other proteins of immunological interest. While new sequences are continually added into this database, we have undertaken the task of developing more analytical methods to study the information content of this collection of aligned sequences. New examples of analysis will be illustrated on a yearly basis. The Kabat Database and its applications are freely available at http://immuno.bme.nwu.edu.
Sipuleucel-T for the treatment of metastatic prostate cancer (2012)

In the past 18 mo, three new life-prolonging therapies have been approved by the US. Food and Drug Administration for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC), including sipuleucel-T, the first therapeutic vaccine approved for this disease. With very low toxicity and a demonstrable overall survival benefit, sipuleucel-T offers a promising new therapy and validates further investigation into other immunotherapy approaches for prostate cancer patients. However, questions about its mechanism of action, concerns about its cost, and its optimal sequencing in the prostate cancer treatment landscape may be limiting the adoption of sipuleucel-T. This review summarizes the state-of-the-science with respect to immunotherapy approaches for men with prostate cancer, provides information about the clinical development as well as the strengths and concerns associated with sipuleucel-T, and offers initial insights about where this promising treatment may best fit in the therapeutic landscape.
Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease (2000)

The concomitant enhanced expression of NGF and its receptor suggests activation of this pathway in chronic inflammation in CD and UC. The presence of NGF and TrkA in both neural and non-neural structures in CD and UC supports the hypothesis that neuroimmune interactions occur and are activated in both disorders.
Development of a Spray Scrubbing Process for Post Combustion CO2 Capture with Amine Based Solvents (2014)

The application of a spray tower for CO2 capture instead of a packed absorber column promises substantial advantages, such as reduction of investment and operating costs due to the omission of expensive packing and an insignificant pressure drop. Additionally, a spray scrubbing process offers the opportunity to use precipitating solvents. Moreover, a much higher flexibility of the process towards load changes is expected, because there is no packing that has to be permanently wetted, and no close fluid-dynamical limitations exist for the gas and liquid flow rate. In order to demonstrate the applicability of a spray scrubbing process for CO2 capture and to investigate the most important process and design parameters, a two-way experimental approach was chosen. In laboratory scale experiments, the kinetics of CO2 absorption by single solvent droplets was measured for variations of the process parameters CO2 partial pressure, solvent loading and droplet size. Additionally, a prototype spray scrubber plant designed for treating upto 150 m3 N/h raw gas was put into operation for testing the closed loop absorption – desorption process.
Glucose Sensing in Pancreatic β-Cells (2001)

Nutrient homeostasis is known to be regulated by pancreatic islet tissue. The function of islet beta-cells is controlled by a glucose sensor that operates at physiological glucose concentrations and acts in synergy with signals that integrate messages originating from hypothalamic neurons and endocrine cells in gut and pancreas. Evidence exists that the extrapancreatic cells producing and secreting these (neuro)endocrine signals also exhibit a glucose sensor and an ability to integrate nutrient and (neuro)hormonal messages. Similarities in these cellular and molecular pathways provide a basis for a network of coordinated functions between distant cell groups, which is necessary for an appropriate control of nutrient homeostasis. The glucose sensor seems to be a fundamental component of these control mechanisms. Its molecular characterization is most advanced in pancreatic beta-cells, with important roles for glucokinase and mitochondrial oxidative fluxes in the regulation of ATP-sensitive K+ channels. Other glucose-sensitive cells in the endocrine pancreas, hypothalamus, and gut were found to share some of these molecular characteristics. We propose that similar metabolic signaling pathways influence the function of pancreatic alpha-cells, hypothalamic neurons, and gastrointestinal endocrine and neural cells.
Wet Chemistry Route to Hydrophobic Blue Fluorescent Nanodiamond (2009)

Hydrophobic blue fluorescent nanodiamond was synthesized by covalent linking of octadecylamine to the surface of nanodiamond particles. The material is easily dispersible in hydrophobic solvents, forming a transparent colloidal solution, and can be used in those applications where stable dispersions of nanodiamond in fuels, polymers or oils are required. Bright blue fluorescence of the octadecylamine-modified nanodiamond opens up new avenues for its use as a non-toxic quantum dot analogue for biomedical imaging of cellular membranes and other hydrophobic components of biological systems. Similar surface modification can be used for other carbon nanoparticles.
Trends in Medical Care Expenditures of US Adults with Arthritis and Other Rheumatic Conditions 1997 to 2005 (2009)

Mean annual ambulatory and prescription expenditures for adults with Arthritis increased far above the rate of medical inflation, offsetting a relative decline in inpatient expenditures. Increases in overall mean and aggregate total expenditures are attributable to the increasing number of adults with Arthritis and at least one comorbid chronic condition. Projected increases in this population suggest that these expenditures will continue to rise.
Apolipoprotein E Alleles and Risk of Coronary Disease (1996)

A meta-analysis was undertaken to assess the impact of apolipoprotein E (apo E) alleles (epsilon 2, epsilon 3, and epsilon 4) on coronary disease in 14 published observational studies (9 clinical coronary disease and 5 coronary angiography). In comparison with epsilon 3, the epsilon 4 allele was associated with greater odds for coronary heart disease, and summary estimates of the odds ratios (ORs) and (95% confidence intervals) for both sexes combined were OR = 0.98 (0.85-1.14) for epsilon 2 and OR = 1.26 (1.13-1.41) for epsilon 4. Separate analyses for men and women showed similar associations. In angiographic studies the relative odds for significant coronary artery disease among both sexes combined was OR = 0.76 (0.55-1.05) for epsilon 2 and OR = 1.11 (0.88-1.40) for epsilon 4. The overall impression is that epsilon 4 is associated with clinical and coronary disease and that results are similar in men and women.
Effects of an External Nasal Strip and Furosemide on Pulmonary Hemorrhage in Exercising Thoroughbreds (2001)

Both an external nasal strip device (FLAIR) and furosemide significantly attenuated pulmonary hemorrhage in Thoroughbred horses following a 2-minute bout of high-speed treadmill exercise. Given the purported ergogenic effects of furosemide and the general concerns associated with drug use in racehorses, the external nasal strip is a viable alternative for the attenuation of exerciseinduced pulmonary hemorrhage. Authors’ addresses: Kentucky Equine Research, Inc., 3910 Delaney Ferry Road, Versailles, KY 40383 (Geor and Pagan); EquiGym Products, LLC, 278 Clintonville Rd., Paris, KY 40361 (Ommundson); CNS Inc., 7615 Smetana Lane, Minneapolis, MN 55439 (Fenton). © 2001 AAEP.